Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T02:45:30.844Z Has data issue: false hasContentIssue false

Appetite testing in HIV-infected African adults recovering from malnutrition and given antiretroviral therapy

Published online by Cambridge University Press:  01 May 2014

Andrea M Rehman
Affiliation:
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Susannah Woodd
Affiliation:
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Molly Chisenga
Affiliation:
University Teaching Hospital, Lusaka, Zambia
Joshua Siame
Affiliation:
University Teaching Hospital, Lusaka, Zambia
Gemma Sampson
Affiliation:
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
George PrayGod
Affiliation:
National Institute of Medical Research, Mwanza, Tanzania
John R Koethe
Affiliation:
Vanderbilt University School of Medicine, Nashville, TN, USA
Paul Kelly
Affiliation:
University Teaching Hospital, Lusaka, Zambia
Suzanne Filteau*
Affiliation:
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
*
* Corresponding author: Email Suzanne.Filteau@lshtm.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Objective

The Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial was designed to determine whether nutritional support for malnourished HIV-infected adults starting antiretroviral therapy (ART) can improve early survival. Appetite is related to health outcomes in this population, but the optimal appetite metric for field use is uncertain. We evaluated two measures of appetite with the goal of improving understanding and treatment of malnutrition in HIV-infected adults.

Design

Longitudinal cohort study embedded in a clinical trial of vitamin and mineral-fortified, v. unfortified, lipid-based nutritional supplements.

Setting

HIV clinics in Mwanza, Tanzania and Lusaka, Zambia.

Subjects

Malnourished (BMI<18·5 kg/m2) HIV-infected adults starting ART.

Results

Appetite measurements, by short questionnaire and by weight of maize porridge consumed in a standardized test, were compared across time and correlated with changes in weight. Appetite questionnaire scores, from polychoric correlation, and porridge test results were normally distributed for Tanzanians (n 187) but clustered and unreliable for Zambians (n 297). Among Tanzanian patients, the appetite score increased rapidly from referral for ART, plateaued at the start of ART and then increased slowly during the 12-week follow-up. Change in appetite questionnaire score, but not porridge test, correlated with weight change in the corresponding two-week intervals (P=0·002) or over the whole study (P=0·05) but a point estimate of hunger did not predict weight change (P=0·4).

Conclusions

In Tanzania change in appetite score correlated with weight change, but single point measurements did not. Appetite increases several weeks after the start of ART, which may be an appropriate time for nutritional interventions for malnourished HIV-infected adults.

Information

Type
Research Papers
Copyright
Copyright © The Authors 2014 
Figure 0

Table 1Appetite questionnaire and baseline responses; Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial

Figure 1

Fig. 1(colour online) Flow diagram of patients included in the Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial (LNS, lipid-based nutritional supplement)

Figure 2

Fig. 2Spline curves of participant weight over time for patients starting antiretroviral therapy (ART) 14–20 d after recruitment (Recr) for (a) fifty-seven Tanzanian women, (b) forty-six Tanzanian men, (c) forty-four Zambian women and (d) forty-seven Zambian men; Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial

Figure 3

Table 2Baseline characteristics of the study population; Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial

Figure 4

Fig. 3Spline curve of appetite questionnaire score over time in 103 Tanzanian patients starting antiretroviral therapy (ART) 14–20 d after recruitment (Recr); Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial. Lines – – – – – represent 95 % CI and are zero at week 0 because the analysis used forced the curves through 0

Figure 5

Fig. 4Box-and-whisker plots showing consumption of porridge over time by 187 Tanzanian patients (a) and 297 Zambian patients (b, c) starting antiretroviral therapy (ART) 14–20 d after recruitment (Recr); Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial. Line inside the box represents the median; the bottom and top of the box represent the 25th and 75th percentile, respectively (i.e. the interquartile range); the whiskers indicate an additional 1·5×the interquartile range; and open circles represent outliers. Amount of porridge offered in the first bowl was 250 g in (a) and (b), 400 g in (c). In (b), squares denote tests after the 400 g test period in Zambia (July/August 2012) and before the decision to stop appetite testing in Zambia (September 2012)

Figure 6

Table 3Mean weight gain (g/d) and 95 % confidence interval in relation to change in appetite for the same period in Tanzanian patients; Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial